Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 66,650 clinical trials worldwide
Search
Showing 23151-23200 of 66,650 trials
Active filters:
Status: Recruiting
Clinical Trials (66,650)
NCT06232954
Evaluation of the Protective Efficacy of a Spatial Repellent to Reduce Malaria Prevalence in Uganda
NA
Recruiting
5,600 participants
Started: Jun 5, 2024 · Completed: Sep 30, 2025
2 conditions
3 sponsors
1 location
NCT06277219
A First-in-Human, Phase 1/2 Study of LAT010 in Patients With Advanced Solid Tumors (LIGHTSPEED-1)
PHASE1/PHASE2
Recruiting
150 participants
Started: Jun 5, 2024 · Completed: Mar 31, 2027
1 condition
1 sponsor
4 locations
NCT06332755
Study to Evaluate LB-LR1109 for the Treatment of Solid Tumors
PHASE1
Recruiting
42 participants
Started: Jun 5, 2024 · Completed: Feb 28, 2027
5 conditions
1 sponsor
1 location
NCT06395220
Kinectics of Donor-specific Anti-HLA Antibody After HLA-incompatible Allogeneic Haematopoietic Stem Cell Transplantation
N/A
Recruiting
800 participants
Started: Jun 5, 2024 · Completed: Jan 1, 2026
1 condition
5 sponsors
1 location
NCT06147531
Delayed Cold-Stored Platelets -PLTS-1
PHASE2
Recruiting
150 participants
Started: Jun 5, 2024 · Completed: Dec 31, 2026
4 conditions
3 sponsors
2 locations
NCT06237062
Migraine Survey in Gulf Region
N/A
Recruiting
200 participants
Started: Jun 5, 2024 · Completed: Mar 30, 2025
1 condition
1 sponsor
6 locations
NCT06753214
Telemedicine Education for Caregivers and Asthma Control in Children
NA
Recruiting
64 participants
Started: Jun 5, 2024 · Completed: Jun 30, 2026
2 conditions
1 sponsor
1 location
NCT05889494
Autologous Whole Blood Management for Transfusion Reduction in Adult Cardiac Surgery Patients
NA
Recruiting
64 participants
Started: Jun 5, 2024 · Completed: Jun 30, 2026
3 conditions
4 sponsors
1 location
NCT06358859
Delta GREENS Food is Medicine Intervention
NA
Recruiting
300 participants
Started: Jun 5, 2024 · Completed: May 31, 2027
5 conditions
5 sponsors
1 location
NCT06188754
Healthy Lifestyles for Bipolar Disorder
NA
Recruiting
300 participants
Started: Jun 5, 2024 · Completed: Feb 28, 2029
2 conditions
7 sponsors
1 location
NCT06112314
IMC-F106C Regimen Versus Nivolumab Regimens in Previously Untreated Advanced Melanoma (PRISM-MEL-301)
PHASE3
Recruiting
680 participants
Started: Jun 5, 2024 · Completed: Oct 16, 2027
1 condition
1 sponsor
174 locations
NCT05815628
Next-Generation-Sequencing Approach to Neutropenic Sepsis
N/A
Recruiting
400 participants
Started: Jun 5, 2024 · Completed: Nov 1, 2026
1 condition
2 sponsors
6 locations
NCT07092007
NWRD09 for HPV-16 Related Intraepithelial Neoplasia and Cervical Cancer
NA
Recruiting
18 participants
Started: Jun 5, 2024 · Completed: Dec 31, 2025
2 conditions
1 sponsor
1 location
NCT06608563
The Effect of an Adhesive System on the Retention and Caries Prevention for Fissure Sealants in Permanent Molars
NA
Recruiting
100 participants
Started: Jun 5, 2024 · Completed: Jun 5, 2027
2 conditions
1 sponsor
1 location
NCT06097832
Study of NXC-201 CAR-T in Patients With Light Chain (AL) Amyloidosis
PHASE1/PHASE2
Recruiting
40 participants
Started: Jun 5, 2024 · Completed: Jan 31, 2039
1 condition
2 sponsors
18 locations
NCT06371404
Imaging Traumatic Stress and Alcohol Use Disorder With [18F]Bavarostat
N/A
Recruiting
150 participants
Started: Jun 5, 2024 · Completed: Jun 1, 2031
2 conditions
2 sponsors
1 location
NCT06073171
Genomic Study of Cutis Tricolor
NA
Recruiting
10 participants
Started: Jun 5, 2024 · Completed: Dec 31, 2026
1 condition
2 sponsors
1 location
NCT06270316
Safety, PK/PD, and Exploratory Efficacy Study of AMT-191 in Classic Fabry Disease
PHASE1/PHASE2
Recruiting
12 participants
Started: Jun 5, 2024 · Completed: Apr 30, 2031
1 condition
1 sponsor
8 locations
NCT05425615
Language Processing and TMS
NA
Recruiting
135 participants
Started: Jun 5, 2024 · Completed: Jun 30, 2032
3 conditions
1 sponsor
1 location
NCT05813964
Efficacy, Acceptability and Safety of Event-driven HIV PrEP Using TAF/FTC in MSM in Thailand and France.
PHASE3
Recruiting
524 participants
Started: Jun 5, 2024 · Completed: May 31, 2027
1 condition
5 sponsors
4 locations
NCT06477614
Anti-cancer DC Cell Vaccination to Treat Solid Tumors
PHASE1
Recruiting
60 participants
Started: Jun 5, 2024 · Completed: Dec 30, 2035
2 conditions
1 sponsor
1 location
NCT06775223
Assessment of Validity and Reliability of the Turkish Version of the Quality of Life and Related Events Assessment Scale for Pacemaker Patients
N/A
Recruiting
120 participants
Started: Jun 5, 2024 · Completed: Jun 30, 2025
2 conditions
2 sponsors
1 location
NCT05321992
Evaluating a Community-Based Behaviour Change Communication Model to Prevent Cholangiocarcinoma in Khon Kaen, Thailand
NA
Recruiting
480 participants
Started: Jun 5, 2024 · Completed: Apr 1, 2026
3 conditions
4 sponsors
1 location
NCT06385353
DVT Burden and the Risk of Post-thrombotic Syndrome
NA
Recruiting
400 participants
Started: Jun 5, 2024 · Completed: Jun 30, 2027
1 condition
3 sponsors
23 locations
NCT06455709
Markers of Favorable Response to Complement Inhibitors Therapy
N/A
Recruiting
50 participants
Started: Jun 5, 2024 · Completed: Jun 1, 2026
1 condition
1 sponsor
1 location
NCT06290713
Vasodilator and Exercise Study for DMD (VASO-REx)
PHASE2
Recruiting
50 participants
Started: Jun 5, 2024 · Completed: Nov 30, 2026
7 conditions
2 sponsors
1 location
NCT06475326
Adebrelimab in Combination With NALIRIFOX in Locally Advanced Pancreatic Cancer
PHASE2
Recruiting
87 participants
Started: Jun 5, 2024 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT06397573
Ablative Stereotactic MR-Guided Adaptive Reirradiation
NA
Recruiting
10 participants
Started: Jun 5, 2024 · Completed: Jun 30, 2027
2 conditions
2 sponsors
1 location
NCT06102902
Testing the Addition of Anti-cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment, Cetuximab Plus Encorafenib, for Colorectal Cancer
PHASE1
Recruiting
30 participants
Started: Jun 5, 2024 · Completed: Jan 30, 2027
4 conditions
1 sponsor
12 locations
NCT06450067
Inaticabtagene Autoleucel Injection Treatment for Adult Relapsed or Refractory Acute Lymphocytic Leukemia
N/A
Recruiting
200 participants
Started: Jun 5, 2024 · Completed: Jun 5, 2029
1 condition
1 sponsor
10 locations
NCT06720779
Virtual Rehabilitation Platform for Patients With Knee Prothesis
NA
Recruiting
20 participants
Started: Jun 5, 2024 · Completed: Jul 5, 2025
1 condition
2 sponsors
1 location
NCT06159777
Pre-operative Polyethylene Glycol 3350 for Minimally Invasive Urogynecologic Surgery
PHASE4
Recruiting
74 participants
Started: Jun 5, 2024 · Completed: Dec 1, 2025
3 conditions
1 sponsor
1 location
NCT06531304
Patient-therapist INTERaction During RObotic GAIT Rehabilitation After Spinal Cord Injury
NA
Recruiting
30 participants
Started: Jun 5, 2024 · Completed: May 31, 2025
1 condition
2 sponsors
1 location
NCT06724848
A Translational Study for Prediction of Biomarkers and Identification of Phenotype and Endotype of COPD and Early COPD Outcomes in Chinese Population
N/A
Recruiting
850 participants
Started: Jun 5, 2024 · Completed: Jul 7, 2027
1 condition
1 sponsor
12 locations
NCT06410976
Prospective Clinical Assessment Study in Children With Hypochondroplasia
N/A
Recruiting
150 participants
Started: Jun 5, 2024 · Completed: Oct 31, 2026
1 condition
1 sponsor
25 locations
NCT06528847
Adjuvant Benmelstobart for Stage IB, Grade 3 Invasive Lung Adenocarcinoma
PHASE2
Recruiting
62 participants
Started: Jun 5, 2024 · Completed: Jun 30, 2030
1 condition
1 sponsor
1 location
NCT06048718
T-DXd Therapy for HER2-low Breast Cancer Patients With Brain Metastases
PHASE2
Recruiting
27 participants
Started: Jun 5, 2024 · Completed: Jul 31, 2026
2 conditions
2 sponsors
13 locations
NCT06339203
Wound Irrigation With Saline Versus Hypodilute-chlorhexidine After Cesarean Section (WISHES Study)
NA
Recruiting
400 participants
Started: Jun 5, 2024 · Completed: Dec 31, 2026
2 conditions
2 sponsors
1 location
NCT06111651
Family-Based Prevention With Black and Latinx Children
NA
Recruiting
60 participants
Started: Jun 5, 2024 · Completed: Feb 1, 2026
2 conditions
2 sponsors
1 location
NCT06458413
Utidelone Capsule Plus Capecitabine (CAP) for Metastatic Breast Cancer
PHASE2
Recruiting
40 participants
Started: Jun 5, 2024 · Completed: Dec 5, 2025
1 condition
2 sponsors
1 location
NCT06430801
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
PHASE3
Recruiting
1,200 participants
Started: Jun 5, 2024 · Completed: Nov 12, 2029
1 condition
1 sponsor
453 locations
NCT06516900
Reducing Foot Pain and Peak Plantar Pressure in Patients With Foot Pain
NA
Recruiting
50 participants
Started: Jun 5, 2024 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT06321432
Intensive Weight Loss Intervention Versus Usual Care for Adults With Obesity
NA
Recruiting
400 participants
Started: Jun 5, 2024 · Completed: Dec 31, 2048
1 condition
5 sponsors
9 locations
NCT06472557
Spinocerebellar Ataxia Type 27B Natural History Study (SCA27B-NHS)
N/A
Recruiting
300 participants
Started: Jun 4, 2024 · Completed: Dec 31, 2028
1 condition
1 sponsor
4 locations
NCT06479980
Single Session Narrative Therapy Study
NA
Recruiting
60 participants
Started: Jun 4, 2024 · Completed: Dec 31, 2025
3 conditions
2 sponsors
1 location
NCT06323824
Office-based Methadone Versus Buprenorphine to Address Retention in Medication for Opioid Use Disorder Treatment.
PHASE4
Recruiting
600 participants
Started: Jun 4, 2024 · Completed: May 31, 2029
1 condition
10 sponsors
6 locations
NCT06092385
SASL Swiss Cirrhosis Cohort
N/A
Recruiting
3,000 participants
Started: Jun 4, 2024 · Completed: Jan 31, 2033
1 condition
1 sponsor
10 locations
NCT06639867
Sensor-based Physiotherapy Intervention with Virtual Reality
NA
Recruiting
50 participants
Started: Jun 4, 2024 · Completed: Apr 2, 2026
1 condition
2 sponsors
2 locations
NCT06229912
A Phase II Study of the Menin Inhibitor Revumenib in Leukemia Associated With Upregulation of HOX Genes
PHASE2
Recruiting
40 participants
Started: Jun 4, 2024 · Completed: Dec 1, 2028
2 conditions
2 sponsors
2 locations
NCT05032105
The Impact of Focused Ultrasound Thalamotomy of the Anterior Nucleus for Focal-Onset Epilepsy on Anxiety
PHASE1
Recruiting
10 participants
Started: Jun 4, 2024 · Completed: Dec 31, 2025
2 conditions
1 sponsor
1 location
Previous
1
More pages
461
462
463
464
465
466
467
More pages
1333
Next